세계의 수술중 신경 모니터링 시장 (2023년-2032년) : 제품 및 서비스 (시스템, 부속품, 서비스), 공급업체 유형 (인소싱 모니터링, 아웃소싱 모니터링), 용도 (척추 수술, 신경 수술, 정형 외과 수술, 이비인후과 수술, 혈관 수술, 기타 수술), 양식별 (운동 유발 전위 (MEP), 체성 감각 유발 전위 (SSEP), 뇌파 (EEG), 근전도 (EMG), 뇌간 청각 유발 전위 (BAEP), 시각 유발 전위 (VEP)), 최종 용도별 (병원, 외래 수술센터 (ASC))

■ 영문 제목 : Intraoperative Neuromonitoring Market By Products and Services (Systems, Accessories, Services), By Source Type (Insourced Monitoring, Outsourced Monitoring), By Application (Spinal Surgery, Neurosurgery, Orthopedic Surgery, ENT Surgery, Vascular Surgery, Other surgeries), By Modality (Motor evoked potentials (MEPs), Somatosensory evoked potentials (SSEPs), Electroencephalography (EEG), Electromyography (EMG), Brainstem auditory evoked potentials (BAEPs), Visual evoked potentials (VEPs)), By End User (Hospitals, Ambulatory Surgical Centers (ASCs)): Global Opportunity Analysis and Industry Forecast, 2023-2032

Allied Market Research 회사가 출판한 조사자료로, 코드는 ALD24FEB183 입니다.■ 상품코드 : ALD24FEB183
■ 조사/발행회사 : Allied Market Research
■ 발행일 : 2023년 12월
■ 페이지수 : 251
■ 작성언어 : 영어
■ 보고서 형태 : PDF
■ 납품 방식 : E메일
■ 조사대상 지역 : 세계
■ 산업 분야 : 생명 과학
■ 판매가격 / 옵션 (부가세 10% 별도)
Single UserUSD5,730 ⇒환산￦8,022,000견적의뢰/주문/질문
5 UserUSD6,450 ⇒환산￦9,030,000견적의뢰/주문/질문
Enterprise UserUSD9,600 ⇒환산￦13,440,000견적의뢰/구입/질문
※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
1. 소개
2. 개요
3. 시장 개요
4. 세계의 수술중 신경 모니터링 시장 규모 : 제품 및 서비스별
5. 세계의 수술중 신경 모니터링 시장 규모 : 공급원 유형별
6. 세계의 수술중 신경 모니터링 시장 규모 : 응용 분야별
7. 세계의 수술중 신경 모니터링 시장 규모 : 모달리티별
8. 세계의 수술중 신경 모니터링 시장 규모 : 최종 용도별
9. 세계의 수술중 신경 모니터링 시장 규모 : 지역별
10. 경쟁 현황
11. 기업 정보
■ 보고서 개요

글로벌 수술중 신경 모니터링 시장은 2022년 48억 1,915만 달러로 평가되며, 2023년부터 2032년까지 연평균 6.1%의 성장률을 기록해 2032년에는 87억 2,930만 달러에 달할 것으로 예상됩니다. 수술중 신경 모니터링(IONM)은 신경계와 관련된 수술 후 신경 장애의 위험을 줄이는 기술로, 수술 중 신경계로부터 전위를 기록하여 수술 후 신경계 손상의 위험을 줄이는 기술입니다. 신경 모니터링의 사용은 부상이 심각해지기 전에 발견할 수 있는 기회를 제공합니다. 따라서 IONM의 도입은 근력 약화, 마비, 청력 상실 및 기타 정상적인 신체 기능 상실과 같은 쇠약성 결함의 위험을 줄일 수 있습니다.
수술중 신경 모니터링 시장의 성장을 촉진하는 주요 요인은 신경 질환, 심혈관 질환, 골관절염과 같은 만성 질환의 유행입니다. 이러한 질환은 외과적 개입이 필요한 경우가 많으며, 수술중 신경 모니터링은 수술의 정확성을 높이고 합병증을 최소화하는 매우 중요한 도구로 부상하고 있습니다. 또한, 수술 건수의 증가는 시장 성장을 더욱 촉진할 것입니다. 예를 들어, 디지털 헬스 기업 Etiometry Inc.가 2022년에 발표한 백서에 따르면, 미국에서는 연간 약 90만 건의 심장 수술이 이루어지고 있으며, 수술 건수는 연평균 5%씩 증가하고 있습니다. 또한, 인구 고령화에 따라 만성질환의 유병률이 급증하고 복잡한 수술의 빈도가 높아질 것으로 예상됩니다. 이러한 인구 통계학적 변화는 첨단 수술에 필수적인 요소인 수술중 신경 모니터링의 지속적인 시장 성장을 촉진하는 주요 원동력이 될 것으로 예상됩니다.

또한, 유리한 상환 정책의 존재는 수술중 신경 모니터링 시장의 견고한 성장에 크게 기여하고 있습니다. 의료 시스템이 수술 중 환자의 안전을 보장하는 데 있어 이러한 모니터링 기술의 중요성을 인식함에 따라 의료 제공자가 수술중 신경 모니터링을 진료에 통합할 수 있는 동기를 부여하는 지원적인 상환 프레임워크가 있습니다. 이러한 상환 정책은 의료기관의 재정적 부담을 줄여줄 뿐만 아니라, 이러한 첨단 모니터링 솔루션을 보다 광범위하게 도입할 수 있도록 유도하여 보다 친숙하게 다가갈 수 있도록 돕습니다. 이처럼 수술중 신경 모니터링의 장점과 유리한 상환 정책의 결합은 지속적인 시장 확대를 위한 환경을 조성하는 중요한 촉매제 역할을 할 것입니다.

수술중 신경 모니터링 시장은 제품 및 서비스, 소스 유형, 응용 프로그램, 양식, 최종 용도, 지역별로 분류됩니다. 제품 및 서비스별로 시장은 시스템, 액세서리, 서비스로 분류됩니다. 소스 유형에 따라 시장은 인소스 모니터링과 아웃소싱 모니터링으로 분류됩니다. 용도별로는 척추 수술, 신경외과, 혈관 수술, 이비인후과, 정형외과, 기타 수술로 분류됩니다. 양식에 따라 시장은 운동유발전위(MEPs), 체성감각유발전위(SSEPs), 뇌파(EEG), 근전도(EMG), 뇌간청각유발전위(BAEPs), 시각유발전위(VEPs)로 나뉩니다. 최종 용도별로 시장은 병원과 외래 수술센터(ASC)로 구분됩니다. 지역별로는 북미(미국, 캐나다, 멕시코), 유럽(독일, 프랑스, 영국, 이탈리아, 스페인, 기타 유럽 지역), 아시아 태평양(중국, 일본, 인도, 호주, 한국, 기타 아시아 태평양), LAMEA(브라질, 사우디 아라비아, 남아공, LAMEA의 기타 지역)로 분석하고 있습니다.

글로벌 수술중 신경 모니터링 시장에서 활동하는 주요 기업으로는 NuVasive, Inc, Medtronic plc, Natus Medical Incorporated, inomed Medizintechnik GmbH, Nihon Kohden Corporation, Accurate Monitoring, Computational Diagnostics, Medtronic plc, Natus Medical Incorporated, inomed Medizintechnik GmbH, Nihon Kohden Corporation Accurate Monitoring, Computational Diagnostics, Inc., SpecialtyCare, NeuroStyle Pte. Ltd, Intranerve Neuroscience Holdings, LLC. 등이 있습니다.

이해관계자를 위한 주요 혜택
이 보고서는 2022년부터 2032년까지 수술중 신경 모니터링 시장 분석의 시장 부문, 현재 동향, 예측 및 역학을 정량적으로 분석하여 수술중 신경 모니터링 시장의 유력한 시장 기회를 식별합니다.
주요 촉진 요인, 저해요인 및 기회에 대한 정보와 함께 시장 조사를 제공합니다.
포터의 파이브 포스 분석을 통해 구매자와 공급 업체의 잠재력을 파악하고 이해 관계자가 이익 중심의 비즈니스 결정을 내리고 공급 업체 및 구매자 네트워크를 강화할 수 있도록 도와줍니다.
수술중 신경 모니터링 시장의 세분화를 자세히 분석하여 시장 기회를 파악할 수 있습니다.
각 지역의 주요 국가를 세계 시장에 대한 수익 기여도에 따라 매핑합니다.
시장 플레이어의 포지셔닝은 벤치마킹을 용이하게 하고 시장 플레이어의 현재 위치를 명확하게 이해할 수 있도록 도와줍니다.
지역 및 글로벌 수술중 신경 모니터링 시장 동향, 주요 기업, 시장 부문, 응용 분야 및 시장 성장 전략에 대한 분석이 포함되어 있습니다.

본 보고서의 커스터마이징 가능성 (추가 비용 및 일정이 필요합니다.)
규제 가이드라인
고객의 관심사에 특화된 추가 기업 프로파일
국가 또는 지역별 추가 분석 – 시장 규모 및 예측
확장된 기업 프로파일 목록
과거 시장 데이터
주요 플레이어의 세부 정보(위치, 연락처, 공급업체/벤더 네트워크 등 엑셀 형식 포함)

주요 시장 부문
제품 및 서비스별
시스템
액세서리
서비스별

소스 유형별
인소싱 모니터링
아웃소싱 모니터링

용도별
척추외과
신경외과
정형외과
이비인후과
혈관외과
기타 수술

모달리티별
운동유발전위(MEPs)
체성감각유발전위(SSEPs)
뇌파
근전도(EMG)
뇌간청각유발전위(BAEPs)
시각유발전위(VEPs)

최종 용도별
병원
외래수술센터(ASCs)

지역별
북미
미국
캐나다
멕시코
유럽
독일
프랑스
영국
이탈리아
스페인
기타 유럽
아시아 태평양
일본
중국
인도
호주
한국
기타 아시아 태평양
중남미
사우디아라비아
남아프리카공화국
기타 지역

주요 시장 플레이어
Medtronic plc
inomed Medizintechnik GmbH
Nihon Kohden Corporation
Accurate Monitoring
SpecialtyCare
NeuroStyle Pte.
Intranerve Neuroscience Holdings, LLC
Natus Medical Incorporated
Computational Diagnostics, Inc.
NuVasive, Inc.

■ 보고서 목차

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Low bargaining power of suppliers
3.3.2. Low threat of new entrants
3.3.3. Low threat of substitutes
3.3.4. Low intensity of rivalry
3.3.5. Low bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in prevalence of chronic diseases
3.4.1.2. Rise in geriatric population
3.4.1.3. Applications of IONM in various surgeries
3.4.2. Restraints
3.4.2.1. Dearth of skilled professionals
3.4.3. Opportunities
3.4.3.1. Growth opportunities in emerging markets 
CHAPTER 4: INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS AND SERVICES
4.1. Overview
4.1.1. Market size and forecast
4.2. Systems
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Accessories
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Services
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
CHAPTER 5: INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE
5.1. Overview
5.1.1. Market size and forecast
5.2. Insourced Monitoring
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Outsourced Monitoring
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
CHAPTER 6: INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION
6.1. Overview
6.1.1. Market size and forecast
6.2. Spinal Surgery
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Neurosurgery
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Orthopedic Surgery
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
6.5. ENT Surgery
6.5.1. Key market trends, growth factors and opportunities
6.5.2. Market size and forecast, by region
6.5.3. Market share analysis by country
6.6. Vascular Surgery
6.6.1. Key market trends, growth factors and opportunities
6.6.2. Market size and forecast, by region
6.6.3. Market share analysis by country
6.7. Other surgeries
6.7.1. Key market trends, growth factors and opportunities
6.7.2. Market size and forecast, by region
6.7.3. Market share analysis by country
CHAPTER 7: INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY
7.1. Overview
7.1.1. Market size and forecast
7.2. Motor evoked potentials (MEPs)
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by region
7.2.3. Market share analysis by country
7.3. Somatosensory evoked potentials (SSEPs)
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by region
7.3.3. Market share analysis by country
7.4. Electroencephalography (EEG)
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by region
7.4.3. Market share analysis by country
7.5. Electromyography (EMG)
7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market size and forecast, by region
7.5.3. Market share analysis by country
7.6. Brainstem auditory evoked potentials (BAEPs)
7.6.1. Key market trends, growth factors and opportunities
7.6.2. Market size and forecast, by region
7.6.3. Market share analysis by country
7.7. Visual evoked potentials (VEPs)
7.7.1. Key market trends, growth factors and opportunities
7.7.2. Market size and forecast, by region
7.7.3. Market share analysis by country
CHAPTER 8: INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER
8.1. Overview
8.1.1. Market size and forecast
8.2. Hospitals
8.2.1. Key market trends, growth factors and opportunities
8.2.2. Market size and forecast, by region
8.2.3. Market share analysis by country
8.3. Ambulatory Surgical Centers (ASCs)
8.3.1. Key market trends, growth factors and opportunities
8.3.2. Market size and forecast, by region
8.3.3. Market share analysis by country
CHAPTER 9: INTRAOPERATIVE NEUROMONITORING MARKET, BY REGION
9.1. Overview
9.1.1. Market size and forecast By Region
9.2. North America
9.2.1. Key market trends, growth factors and opportunities
9.2.2. Market size and forecast, by Products and Services
9.2.3. Market size and forecast, by Source Type
9.2.4. Market size and forecast, by Application
9.2.5. Market size and forecast, by Modality
9.2.6. Market size and forecast, by End User
9.2.7. Market size and forecast, by country
9.2.7.1. U.S.
9.2.7.1.1. Market size and forecast, by Products and Services
9.2.7.1.2. Market size and forecast, by Source Type
9.2.7.1.3. Market size and forecast, by Application
9.2.7.1.4. Market size and forecast, by Modality
9.2.7.1.5. Market size and forecast, by End User
9.2.7.2. Canada
9.2.7.2.1. Market size and forecast, by Products and Services
9.2.7.2.2. Market size and forecast, by Source Type
9.2.7.2.3. Market size and forecast, by Application
9.2.7.2.4. Market size and forecast, by Modality
9.2.7.2.5. Market size and forecast, by End User
9.2.7.3. Mexico
9.2.7.3.1. Market size and forecast, by Products and Services
9.2.7.3.2. Market size and forecast, by Source Type
9.2.7.3.3. Market size and forecast, by Application
9.2.7.3.4. Market size and forecast, by Modality
9.2.7.3.5. Market size and forecast, by End User
9.3. Europe
9.3.1. Key market trends, growth factors and opportunities
9.3.2. Market size and forecast, by Products and Services
9.3.3. Market size and forecast, by Source Type
9.3.4. Market size and forecast, by Application
9.3.5. Market size and forecast, by Modality
9.3.6. Market size and forecast, by End User
9.3.7. Market size and forecast, by country
9.3.7.1. Germany
9.3.7.1.1. Market size and forecast, by Products and Services
9.3.7.1.2. Market size and forecast, by Source Type
9.3.7.1.3. Market size and forecast, by Application
9.3.7.1.4. Market size and forecast, by Modality
9.3.7.1.5. Market size and forecast, by End User
9.3.7.2. France
9.3.7.2.1. Market size and forecast, by Products and Services
9.3.7.2.2. Market size and forecast, by Source Type
9.3.7.2.3. Market size and forecast, by Application
9.3.7.2.4. Market size and forecast, by Modality
9.3.7.2.5. Market size and forecast, by End User
9.3.7.3. UK
9.3.7.3.1. Market size and forecast, by Products and Services
9.3.7.3.2. Market size and forecast, by Source Type
9.3.7.3.3. Market size and forecast, by Application
9.3.7.3.4. Market size and forecast, by Modality
9.3.7.3.5. Market size and forecast, by End User
9.3.7.4. Italy
9.3.7.4.1. Market size and forecast, by Products and Services
9.3.7.4.2. Market size and forecast, by Source Type
9.3.7.4.3. Market size and forecast, by Application
9.3.7.4.4. Market size and forecast, by Modality
9.3.7.4.5. Market size and forecast, by End User
9.3.7.5. Spain
9.3.7.5.1. Market size and forecast, by Products and Services
9.3.7.5.2. Market size and forecast, by Source Type
9.3.7.5.3. Market size and forecast, by Application
9.3.7.5.4. Market size and forecast, by Modality
9.3.7.5.5. Market size and forecast, by End User
9.3.7.6. Rest of Europe
9.3.7.6.1. Market size and forecast, by Products and Services
9.3.7.6.2. Market size and forecast, by Source Type
9.3.7.6.3. Market size and forecast, by Application
9.3.7.6.4. Market size and forecast, by Modality
9.3.7.6.5. Market size and forecast, by End User
9.4. Asia-Pacific
9.4.1. Key market trends, growth factors and opportunities
9.4.2. Market size and forecast, by Products and Services
9.4.3. Market size and forecast, by Source Type
9.4.4. Market size and forecast, by Application
9.4.5. Market size and forecast, by Modality
9.4.6. Market size and forecast, by End User
9.4.7. Market size and forecast, by country
9.4.7.1. Japan
9.4.7.1.1. Market size and forecast, by Products and Services
9.4.7.1.2. Market size and forecast, by Source Type
9.4.7.1.3. Market size and forecast, by Application
9.4.7.1.4. Market size and forecast, by Modality
9.4.7.1.5. Market size and forecast, by End User
9.4.7.2. China
9.4.7.2.1. Market size and forecast, by Products and Services
9.4.7.2.2. Market size and forecast, by Source Type
9.4.7.2.3. Market size and forecast, by Application
9.4.7.2.4. Market size and forecast, by Modality
9.4.7.2.5. Market size and forecast, by End User
9.4.7.3. India
9.4.7.3.1. Market size and forecast, by Products and Services
9.4.7.3.2. Market size and forecast, by Source Type
9.4.7.3.3. Market size and forecast, by Application
9.4.7.3.4. Market size and forecast, by Modality
9.4.7.3.5. Market size and forecast, by End User
9.4.7.4. Australia
9.4.7.4.1. Market size and forecast, by Products and Services
9.4.7.4.2. Market size and forecast, by Source Type
9.4.7.4.3. Market size and forecast, by Application
9.4.7.4.4. Market size and forecast, by Modality
9.4.7.4.5. Market size and forecast, by End User
9.4.7.5. South Korea
9.4.7.5.1. Market size and forecast, by Products and Services
9.4.7.5.2. Market size and forecast, by Source Type
9.4.7.5.3. Market size and forecast, by Application
9.4.7.5.4. Market size and forecast, by Modality
9.4.7.5.5. Market size and forecast, by End User
9.4.7.6. Rest of Asia-Pacific
9.4.7.6.1. Market size and forecast, by Products and Services
9.4.7.6.2. Market size and forecast, by Source Type
9.4.7.6.3. Market size and forecast, by Application
9.4.7.6.4. Market size and forecast, by Modality
9.4.7.6.5. Market size and forecast, by End User
9.5. LAMEA
9.5.1. Key market trends, growth factors and opportunities
9.5.2. Market size and forecast, by Products and Services
9.5.3. Market size and forecast, by Source Type
9.5.4. Market size and forecast, by Application
9.5.5. Market size and forecast, by Modality
9.5.6. Market size and forecast, by End User
9.5.7. Market size and forecast, by country
9.5.7.1. Brazil
9.5.7.1.1. Market size and forecast, by Products and Services
9.5.7.1.2. Market size and forecast, by Source Type
9.5.7.1.3. Market size and forecast, by Application
9.5.7.1.4. Market size and forecast, by Modality
9.5.7.1.5. Market size and forecast, by End User
9.5.7.2. Saudi Arabia
9.5.7.2.1. Market size and forecast, by Products and Services
9.5.7.2.2. Market size and forecast, by Source Type
9.5.7.2.3. Market size and forecast, by Application
9.5.7.2.4. Market size and forecast, by Modality
9.5.7.2.5. Market size and forecast, by End User
9.5.7.3. South Africa
9.5.7.3.1. Market size and forecast, by Products and Services
9.5.7.3.2. Market size and forecast, by Source Type
9.5.7.3.3. Market size and forecast, by Application
9.5.7.3.4. Market size and forecast, by Modality
9.5.7.3.5. Market size and forecast, by End User
9.5.7.4. Rest of LAMEA
9.5.7.4.1. Market size and forecast, by Products and Services
9.5.7.4.2. Market size and forecast, by Source Type
9.5.7.4.3. Market size and forecast, by Application
9.5.7.4.4. Market size and forecast, by Modality
9.5.7.4.5. Market size and forecast, by End User
CHAPTER 10: COMPETITIVE LANDSCAPE
10.1. Introduction
10.2. Top winning strategies
10.3. Product mapping of top 10 player
10.4. Competitive dashboard
10.5. Competitive heatmap
10.6. Top player positioning, 2022
CHAPTER 11: COMPANY PROFILES
11.1. NuVasive, Inc.
11.1.1. Company overview
11.1.2. Key executives
11.1.3. Company snapshot
11.1.4. Operating business segments
11.1.5. Product portfolio
11.1.6. Business performance
11.2. Medtronic plc
11.2.1. Company overview
11.2.2. Key executives
11.2.3. Company snapshot
11.2.4. Operating business segments
11.2.5. Product portfolio
11.2.6. Business performance
11.2.7. Key strategic moves and developments
11.3. Computational Diagnostics, Inc.
11.3.1. Company overview
11.3.2. Key executives
11.3.3. Company snapshot
11.3.4. Operating business segments
11.3.5. Product portfolio
11.4. Natus Medical Incorporated.
11.4.1. Company overview
11.4.2. Key executives
11.4.3. Company snapshot
11.4.4. Operating business segments
11.4.5. Product portfolio
11.4.6. Business performance
11.5. Accurate Monitoring
11.5.1. Company overview
11.5.2. Key executives
11.5.3. Company snapshot
11.5.4. Operating business segments
11.5.5. Product portfolio
11.6. inomed Medizintechnik GmbH
11.6.1. Company overview
11.6.2. Key executives
11.6.3. Company snapshot
11.6.4. Operating business segments
11.6.5. Product portfolio
11.7. Nihon Kohden Corporation
11.7.1. Company overview
11.7.2. Key executives
11.7.3. Company snapshot
11.7.4. Operating business segments
11.7.5. Product portfolio
11.7.6. Business performance
11.8. SpecialtyCare
11.8.1. Company overview
11.8.2. Key executives
11.8.3. Company snapshot
11.8.4. Operating business segments
11.8.5. Product portfolio
11.9. Intranerve Neuroscience Holdings, LLC
11.9.1. Company overview
11.9.2. Key executives
11.9.3. Company snapshot
11.9.4. Operating business segments
11.9.5. Product portfolio
11.9.6. Key strategic moves and developments
11.10. NeuroStyle Pte.Ltd
11.10.1. Company overview
11.10.2. Key executives
11.10.3. Company snapshot
11.10.4. Operating business segments
11.10.5. Product portfolio

LIST OF TABLES
TABLE 01. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS AND SERVICES, 2022-2032 ($MILLION)
TABLE 02. INTRAOPERATIVE NEUROMONITORING MARKET FOR SYSTEMS, BY REGION, 2022-2032 ($MILLION)
TABLE 03. INTRAOPERATIVE NEUROMONITORING MARKET FOR ACCESSORIES, BY REGION, 2022-2032 ($MILLION)
TABLE 04. INTRAOPERATIVE NEUROMONITORING MARKET FOR SERVICES, BY REGION, 2022-2032 ($MILLION)
TABLE 05. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE, 2022-2032 ($MILLION)
TABLE 06. INTRAOPERATIVE NEUROMONITORING MARKET FOR INSOURCED MONITORING, BY REGION, 2022-2032 ($MILLION)
TABLE 07. INTRAOPERATIVE NEUROMONITORING MARKET FOR OUTSOURCED MONITORING, BY REGION, 2022-2032 ($MILLION)
TABLE 08. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 09. INTRAOPERATIVE NEUROMONITORING MARKET FOR SPINAL SURGERY, BY REGION, 2022-2032 ($MILLION)
TABLE 10. INTRAOPERATIVE NEUROMONITORING MARKET FOR NEUROSURGERY, BY REGION, 2022-2032 ($MILLION)
TABLE 11. INTRAOPERATIVE NEUROMONITORING MARKET FOR ORTHOPEDIC SURGERY, BY REGION, 2022-2032 ($MILLION)
TABLE 12. INTRAOPERATIVE NEUROMONITORING MARKET FOR ENT SURGERY, BY REGION, 2022-2032 ($MILLION)
TABLE 13. INTRAOPERATIVE NEUROMONITORING MARKET FOR VASCULAR SURGERY, BY REGION, 2022-2032 ($MILLION)
TABLE 14. INTRAOPERATIVE NEUROMONITORING MARKET FOR OTHER SURGERIES, BY REGION, 2022-2032 ($MILLION)
TABLE 15. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY, 2022-2032 ($MILLION)
TABLE 16. INTRAOPERATIVE NEUROMONITORING MARKET FOR MOTOR EVOKED POTENTIALS (MEPS), BY REGION, 2022-2032 ($MILLION)
TABLE 17. INTRAOPERATIVE NEUROMONITORING MARKET FOR SOMATOSENSORY EVOKED POTENTIALS (SSEPS), BY REGION, 2022-2032 ($MILLION)
TABLE 18. INTRAOPERATIVE NEUROMONITORING MARKET FOR ELECTROENCEPHALOGRAPHY (EEG), BY REGION, 2022-2032 ($MILLION)
TABLE 19. INTRAOPERATIVE NEUROMONITORING MARKET FOR ELECTROMYOGRAPHY (EMG), BY REGION, 2022-2032 ($MILLION)
TABLE 20. INTRAOPERATIVE NEUROMONITORING MARKET FOR BRAINSTEM AUDITORY EVOKED POTENTIALS (BAEPS), BY REGION, 2022-2032 ($MILLION)
TABLE 21. INTRAOPERATIVE NEUROMONITORING MARKET FOR VISUAL EVOKED POTENTIALS (VEPS), BY REGION, 2022-2032 ($MILLION)
TABLE 22. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 23. INTRAOPERATIVE NEUROMONITORING MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
TABLE 24. INTRAOPERATIVE NEUROMONITORING MARKET FOR AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2022-2032 ($MILLION)
TABLE 25. INTRAOPERATIVE NEUROMONITORING MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 26. NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS AND SERVICES, 2022-2032 ($MILLION)
TABLE 27. NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE, 2022-2032 ($MILLION)
TABLE 28. NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 29. NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY, 2022-2032 ($MILLION)
TABLE 30. NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 31. NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 32. U.S. INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS AND SERVICES, 2022-2032 ($MILLION)
TABLE 33. U.S. INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE, 2022-2032 ($MILLION)
TABLE 34. U.S. INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 35. U.S. INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY, 2022-2032 ($MILLION)
TABLE 36. U.S. INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 37. CANADA INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS AND SERVICES, 2022-2032 ($MILLION)
TABLE 38. CANADA INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE, 2022-2032 ($MILLION)
TABLE 39. CANADA INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 40. CANADA INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY, 2022-2032 ($MILLION)
TABLE 41. CANADA INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 42. MEXICO INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS AND SERVICES, 2022-2032 ($MILLION)
TABLE 43. MEXICO INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE, 2022-2032 ($MILLION)
TABLE 44. MEXICO INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 45. MEXICO INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY, 2022-2032 ($MILLION)
TABLE 46. MEXICO INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 47. EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS AND SERVICES, 2022-2032 ($MILLION)
TABLE 48. EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE, 2022-2032 ($MILLION)
TABLE 49. EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 50. EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY, 2022-2032 ($MILLION)
TABLE 51. EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 52. EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 53. GERMANY INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS AND SERVICES, 2022-2032 ($MILLION)
TABLE 54. GERMANY INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE, 2022-2032 ($MILLION)
TABLE 55. GERMANY INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 56. GERMANY INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY, 2022-2032 ($MILLION)
TABLE 57. GERMANY INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 58. FRANCE INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS AND SERVICES, 2022-2032 ($MILLION)
TABLE 59. FRANCE INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE, 2022-2032 ($MILLION)
TABLE 60. FRANCE INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 61. FRANCE INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY, 2022-2032 ($MILLION)
TABLE 62. FRANCE INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 63. UK INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS AND SERVICES, 2022-2032 ($MILLION)
TABLE 64. UK INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE, 2022-2032 ($MILLION)
TABLE 65. UK INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 66. UK INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY, 2022-2032 ($MILLION)
TABLE 67. UK INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 68. ITALY INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS AND SERVICES, 2022-2032 ($MILLION)
TABLE 69. ITALY INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE, 2022-2032 ($MILLION)
TABLE 70. ITALY INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 71. ITALY INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY, 2022-2032 ($MILLION)
TABLE 72. ITALY INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 73. SPAIN INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS AND SERVICES, 2022-2032 ($MILLION)
TABLE 74. SPAIN INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE, 2022-2032 ($MILLION)
TABLE 75. SPAIN INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 76. SPAIN INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY, 2022-2032 ($MILLION)
TABLE 77. SPAIN INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 78. REST OF EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS AND SERVICES, 2022-2032 ($MILLION)
TABLE 79. REST OF EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE, 2022-2032 ($MILLION)
TABLE 80. REST OF EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 81. REST OF EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY, 2022-2032 ($MILLION)
TABLE 82. REST OF EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 83. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS AND SERVICES, 2022-2032 ($MILLION)
TABLE 84. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE, 2022-2032 ($MILLION)
TABLE 85. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 86. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY, 2022-2032 ($MILLION)
TABLE 87. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 88. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 89. JAPAN INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS AND SERVICES, 2022-2032 ($MILLION)
TABLE 90. JAPAN INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE, 2022-2032 ($MILLION)
TABLE 91. JAPAN INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 92. JAPAN INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY, 2022-2032 ($MILLION)
TABLE 93. JAPAN INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 94. CHINA INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS AND SERVICES, 2022-2032 ($MILLION)
TABLE 95. CHINA INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE, 2022-2032 ($MILLION)
TABLE 96. CHINA INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 97. CHINA INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY, 2022-2032 ($MILLION)
TABLE 98. CHINA INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 99. INDIA INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS AND SERVICES, 2022-2032 ($MILLION)
TABLE 100. INDIA INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE, 2022-2032 ($MILLION)
TABLE 101. INDIA INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 102. INDIA INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY, 2022-2032 ($MILLION)
TABLE 103. INDIA INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 104. AUSTRALIA INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS AND SERVICES, 2022-2032 ($MILLION)
TABLE 105. AUSTRALIA INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE, 2022-2032 ($MILLION)
TABLE 106. AUSTRALIA INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 107. AUSTRALIA INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY, 2022-2032 ($MILLION)
TABLE 108. AUSTRALIA INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 109. SOUTH KOREA INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS AND SERVICES, 2022-2032 ($MILLION)
TABLE 110. SOUTH KOREA INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE, 2022-2032 ($MILLION)
TABLE 111. SOUTH KOREA INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 112. SOUTH KOREA INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY, 2022-2032 ($MILLION)
TABLE 113. SOUTH KOREA INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 114. REST OF ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS AND SERVICES, 2022-2032 ($MILLION)
TABLE 115. REST OF ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE, 2022-2032 ($MILLION)
TABLE 116. REST OF ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 117. REST OF ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY, 2022-2032 ($MILLION)
TABLE 118. REST OF ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 119. LAMEA INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS AND SERVICES, 2022-2032 ($MILLION)
TABLE 120. LAMEA INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE, 2022-2032 ($MILLION)
TABLE 121. LAMEA INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 122. LAMEA INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY, 2022-2032 ($MILLION)
TABLE 123. LAMEA INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 124. LAMEA INTRAOPERATIVE NEUROMONITORING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 125. BRAZIL INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS AND SERVICES, 2022-2032 ($MILLION)
TABLE 126. BRAZIL INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE, 2022-2032 ($MILLION)
TABLE 127. BRAZIL INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 128. BRAZIL INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY, 2022-2032 ($MILLION)
TABLE 129. BRAZIL INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 130. SAUDI ARABIA INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS AND SERVICES, 2022-2032 ($MILLION)
TABLE 131. SAUDI ARABIA INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE, 2022-2032 ($MILLION)
TABLE 132. SAUDI ARABIA INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 133. SAUDI ARABIA INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY, 2022-2032 ($MILLION)
TABLE 134. SAUDI ARABIA INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 135. SOUTH AFRICA INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS AND SERVICES, 2022-2032 ($MILLION)
TABLE 136. SOUTH AFRICA INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE, 2022-2032 ($MILLION)
TABLE 137. SOUTH AFRICA INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 138. SOUTH AFRICA INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY, 2022-2032 ($MILLION)
TABLE 139. SOUTH AFRICA INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 140. REST OF LAMEA INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS AND SERVICES, 2022-2032 ($MILLION)
TABLE 141. REST OF LAMEA INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE, 2022-2032 ($MILLION)
TABLE 142. REST OF LAMEA INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 143. REST OF LAMEA INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY, 2022-2032 ($MILLION)
TABLE 144. REST OF LAMEA INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 145. NUVASIVE, INC.: KEY EXECUTIVES
TABLE 146. NUVASIVE, INC.: COMPANY SNAPSHOT
TABLE 147. NUVASIVE, INC.: PRODUCT SEGMENTS
TABLE 148. NUVASIVE, INC.: PRODUCT PORTFOLIO
TABLE 149. MEDTRONIC PLC: KEY EXECUTIVES
TABLE 150. MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 151. MEDTRONIC PLC: PRODUCT SEGMENTS
TABLE 152. MEDTRONIC PLC: PRODUCT PORTFOLIO
TABLE 153. MEDTRONIC PLC: KEY STRATERGIES
TABLE 154. COMPUTATIONAL DIAGNOSTICS, INC.: KEY EXECUTIVES
TABLE 155. COMPUTATIONAL DIAGNOSTICS, INC.: COMPANY SNAPSHOT
TABLE 156. COMPUTATIONAL DIAGNOSTICS, INC.: SERVICE SEGMENTS
TABLE 157. COMPUTATIONAL DIAGNOSTICS, INC.: PRODUCT PORTFOLIO
TABLE 158. NATUS MEDICAL INCORPORATED.: KEY EXECUTIVES
TABLE 159. NATUS MEDICAL INCORPORATED.: COMPANY SNAPSHOT
TABLE 160. NATUS MEDICAL INCORPORATED.: PRODUCT SEGMENTS
TABLE 161. NATUS MEDICAL INCORPORATED.: PRODUCT PORTFOLIO
TABLE 162. ACCURATE MONITORING: KEY EXECUTIVES
TABLE 163. ACCURATE MONITORING: COMPANY SNAPSHOT
TABLE 164. ACCURATE MONITORING: PRODUCT SEGMENTS
TABLE 165. ACCURATE MONITORING: SERVICE SEGMENTS
TABLE 166. ACCURATE MONITORING: PRODUCT PORTFOLIO
TABLE 167. INOMED MEDIZINTECHNIK GMBH: KEY EXECUTIVES
TABLE 168. INOMED MEDIZINTECHNIK GMBH: COMPANY SNAPSHOT
TABLE 169. INOMED MEDIZINTECHNIK GMBH: PRODUCT SEGMENTS
TABLE 170. INOMED MEDIZINTECHNIK GMBH: SERVICE SEGMENTS
TABLE 171. INOMED MEDIZINTECHNIK GMBH: PRODUCT PORTFOLIO
TABLE 172. NIHON KOHDEN CORPORATION: KEY EXECUTIVES
TABLE 173. NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT
TABLE 174. NIHON KOHDEN CORPORATION: PRODUCT SEGMENTS
TABLE 175. NIHON KOHDEN CORPORATION: PRODUCT PORTFOLIO
TABLE 176. SPECIALTYCARE: KEY EXECUTIVES
TABLE 177. SPECIALTYCARE: COMPANY SNAPSHOT
TABLE 178. SPECIALTYCARE: SERVICE SEGMENTS
TABLE 179. SPECIALTYCARE: PRODUCT PORTFOLIO
TABLE 180. INTRANERVE NEUROSCIENCE HOLDINGS, LLC: KEY EXECUTIVES
TABLE 181. INTRANERVE NEUROSCIENCE HOLDINGS, LLC: COMPANY SNAPSHOT
TABLE 182. INTRANERVE NEUROSCIENCE HOLDINGS, LLC: SERVICE SEGMENTS
TABLE 183. INTRANERVE NEUROSCIENCE HOLDINGS, LLC: PRODUCT PORTFOLIO
TABLE 184. INTRANERVE NEUROSCIENCE HOLDINGS, LLC: KEY STRATERGIES
TABLE 185. NEUROSTYLE PTE.LTD: KEY EXECUTIVES
TABLE 186. NEUROSTYLE PTE.LTD: COMPANY SNAPSHOT
TABLE 187. NEUROSTYLE PTE.LTD: PRODUCT SEGMENTS
TABLE 188. NEUROSTYLE PTE.LTD: PRODUCT PORTFOLIO
보고서 이미지

※본 조사보고서 [세계의 수술중 신경 모니터링 시장 (2023년-2032년) : 제품 및 서비스 (시스템, 부속품, 서비스), 공급업체 유형 (인소싱 모니터링, 아웃소싱 모니터링), 용도 (척추 수술, 신경 수술, 정형 외과 수술, 이비인후과 수술, 혈관 수술, 기타 수술), 양식별 (운동 유발 전위 (MEP), 체성 감각 유발 전위 (SSEP), 뇌파 (EEG), 근전도 (EMG), 뇌간 청각 유발 전위 (BAEP), 시각 유발 전위 (VEP)), 최종 용도별 (병원, 외래 수술센터 (ASC))] (코드 : ALD24FEB183) 판매에 관한 면책사항을 반드시 확인하세요.
※본 조사보고서 [세계의 수술중 신경 모니터링 시장 (2023년-2032년) : 제품 및 서비스 (시스템, 부속품, 서비스), 공급업체 유형 (인소싱 모니터링, 아웃소싱 모니터링), 용도 (척추 수술, 신경 수술, 정형 외과 수술, 이비인후과 수술, 혈관 수술, 기타 수술), 양식별 (운동 유발 전위 (MEP), 체성 감각 유발 전위 (SSEP), 뇌파 (EEG), 근전도 (EMG), 뇌간 청각 유발 전위 (BAEP), 시각 유발 전위 (VEP)), 최종 용도별 (병원, 외래 수술센터 (ASC))] 에 대해서 E메일 문의는 여기를 클릭하세요.
*** 아래는 관련 보고서 소개입니다 ***

  • 세계의 발기 부전 치료제 시장 2023년-2032년 : 제품별 (실데나필, 타다라필, 유데나필, 아바나필, 기타), 투여 방법별 (경구약, 주사제), 유통 채널별 (병원 약국, 소매 약국, 온라인 약국)
    ALD23SEP102 / Allied Market Research / 2023년 4월 / 세계의 발기 부전 치료제 시장은 2022년 26억 달러 규모였으며 2023년부터 2032년까지 6.5%의 연평균 성장률로 성장하여 2032년에는 51억 달러에 이를 것으로 예상됩니다. 발기 부전(ED)은 모든 연령대의 남성에게 영향을 미치는 흔한 성...CHAPTER 1 : 소개 CHAPTER 2 : 개요 CHAPTER 3 : 시장 동향 CHAPTER 4 : 발기 부전 치료제 시장, 제품별 CHAPTER 5 : 발기 부전 치료제 시장, 투여 방법별 CHAPTER 6 : 발기 부전 치료제 시장, 유통 채널별 CHAPTER 7 : 발기 부전 치료제 시장, 지역별 CHAPTER 8 :...
  • 세계의 각막 임플란트 시장 2021년-2031년 : 시술 유형별 (전층 각막 이식, 내피 각막 이식, 기타), 질환별 (원추 각막, 각막 이상증, 감염성 각막염, 기타), 최종 용도별 (병원, 안과 센터, 기타)
    ALD23SEP121 / Allied Market Research / 2023년 4월 / 글로벌 각막 임플란트 시장은 2021년 12억 6,418만 달러로 평가되었으며, 2022년부터 2031년까지 5.3%의 연평균 성장률을 기록하며 2031년에는 21억 2,444만 달러에 달할 것으로 예상됩니다. 각막으로 알려진 안구 덮개의 가장 바깥쪽 반투명 부분은...CHAPTER 1 : 소개 CHAPTER 2 : 개요 CHAPTER 3 : 시장 동향 CHAPTER 4 : 각막 임플란트 시장, 시술 유형별 CHAPTER 5 : 각막 임플란트 시장, 질병 유형별 CHAPTER 6 : 각막 임플란트 시장, 최종 용도별 CHAPTER 7 : 각막 임플란트 시장, 지역별 CHAPTER 8 : 경쟁 현황 CHAPTER...
  • 세계의 인공 관절 시장 2023년-2032년 : 유형별 (시멘트 고정식 인공 관절, 비시멘트 고정식 인공 관절), 용도별 (인공 무릎 관절, 인공 고관절, 기타), 재료별 (세라믹, 합금, 기타), 최종 용도별 (병원, 기타)
    ALD23SEP155 / Allied Market Research / 2023년 6월 / 글로벌 인공 관절 시장은 2022년에 20,235.51백만 달러로 평가되었으며 2023년부터 2032년까지 4.6%의 연평균 성장률을 보이며 2032년에는 31,748.12백만 달러에 달할 것으로 예상됩니다.인공 관절 또는 관절 교체라고도 하는 인공 관절은 인체의 손상되거나 병든...CHAPTER 1 : 소개 CHAPTER 2 : 개요 CHAPTER 3 : 시장 동향 CHAPTER 4 : 인공 관절 시장, 유형별 CHAPTER 5 : 인공 관절 시장, 용도별 CHAPTER 6 : 인공 관절 시장, 재료별 CHAPTER 7 : 인공 관절 시장, 최종 용도별 CHAPTER 8 : 인공 관절 시장, 지역별 CHAPTER...
  • 세계의 네뷸라이저 시장 (2023년-2032년) : 유형별 (제트 네뷸라이저, 초음파 네뷸라이저, 메쉬 네뷸라이저), 제품별 (기기, 부속품), 용도별 (COPD, 천식, 기타), 휴대성 (탁상용, 휴대용), 최종 용도별 (병원, 클리닉, 재택 의료)
    ALD24FEB151 / Allied Market Research / 2023년 11월 / 1. 소개 2. 개요 3. 시장 개요 4. 세계의 네뷸라이저 시장 규모 : 유형별 5. 세계의 네뷸라이저 시장 규모 : 제품별 6. 세계의 네뷸라이저 시장 규모 : 용도별 7. 세계의...네뷸라이저는 약물을 폐에 분무하는 약물 전달 도구입니다. 이 장치는 마우스피스나 마스크를 통해 가압된 공기를 액체에 강제로 통과시켜 미세한 안개를 생성합니다. 이 장치는 만성폐쇄성폐질환(COPD), 천식, 낭포성 섬유증과 같은 호흡기 질환을 치료하기 위한 목적으로 사용됩니다. 네뷸라이저 시장의 성장은 천식, 만성폐쇄성폐질환(COPD), 낭포성 섬유증과 같은 호흡기 질환의 유병률 증가에 의해 주도되고 있습니다. 네뷸라이저는 일반적으로...
  • 세계의 실험용 원심 분리기 시장 (2023년-2032년) : 제품별 (기기, 부속품), 모델별 (탁상형 원심 분리기, 플로어 스탠딩형 원심 분리기), 로터 디자인별 (스윙 버킷 로터, 고정 각도 로터, 수직형 로터), 용도별 (진단, 미생물학, 세포학, 단백질학, 유전체학, 혈액 성분 분리, 기타), 최종 용도별 (병원 및 임상 연구소, 생명 공학 및 제약 회사, 학술 및 연구 기관)
    ALD24FEB164 / Allied Market Research / 2023년 11월 / 1. 소개 2. 개요 3. 시장 개요 4. 세계의 실험용 원심 분리기 시장 규모 : 제품별 5. 세계의 실험용 원심 분리기 시장 규모 : 모델별 6. 세계의 실험용 원심 분리기..."실험용 원심 분리기는 침강 기술을 이용한 구심력 가속을 통해 액체 시료를 분리하는 장치입니다. 혈액 샘플 분리, DNA/RNA 분리, 세포 배양 분리, 바이러스, 단백질, 고분자 연구 등 다양한 용도로 사용할 수 있습니다.글로벌 실험용 원심 분리기 시장의 성장을 이끄는 주요 요인으로는 실험용 원심 분리기의 급속한 기술 발전, 독자적인 로터 설계, 생명공학 및...

    • ※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!